IFF has announced an agreement to acquire Health Wright Products, LLC (HWP), a player in formulation and capsule manufacturing for the dietary supplement industry.
Founded in 1995, HWP is located in Clackamas, Oregon, USA, and is a privately-owned and long-time business partner of IFF’s Health and Biosciences probiotics business. HWP is a global player in the consumer Health and Nutrition industries, providing nutritional supplements. HWP manufactures custom formulations and delivers encapsulation and packaging to meet the industries’ more exacting requirements for probiotic products.
The acquisition will bring formulation and finished format capabilities to IFF’s Health and Biosciences probiotics, natural extracts and botanicals businesses, allowing for innovation in custom formulation and combination products through joint capabilities.
The sale is expected to close in the first quarter of 2022, subject to customary closing conditions and regulatory clearances. The financial terms of the deal have not been disclosed.
Simon Herriott, president, IFF’s Health & Biosciences division, said, “Today’s announcement is driven by our commitment to enhance long-term value to our partners and customers. Producing thousands of unique and complex formulations for the industry’s most trusted brands, Health Wright Products formulation and finished format abilities will allow us to develop new and customized solutions and formats for a broad base of customers.”
Mark Wright, president, Health Wright Products, said, “We look forward to joining IFF’s Health & Biosciences division. Health Wright Products best-in-class quality manufacturing and formulation capabilities, combined with the strong biotech innovation pipeline of IFF’s Health and Biosciences, is an exciting proposition for our customers and employees.”